📰 **Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial**

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a milestone for gene editing.

🔗 https://www.cnbc.com/2026/04/27/crispr-gene-editing-intellia-trial.html

#markets #news